Rhythm Pharmaceuticals (RYTM) Treasury Shares (2016 - 2024)
Historic Treasury Shares for Rhythm Pharmaceuticals (RYTM) over the last 6 years, with Q4 2024 value amounting to $1.8 million.
- Rhythm Pharmaceuticals' Treasury Shares rose 6537.18% to $1.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.8 million, marking a year-over-year increase of 6537.18%. This contributed to the annual value of $1.8 million for FY2024, which is 6537.18% up from last year.
- According to the latest figures from Q4 2024, Rhythm Pharmaceuticals' Treasury Shares is $1.8 million, which was up 6537.18% from $1.1 million recorded in Q4 2023.
- In the past 5 years, Rhythm Pharmaceuticals' Treasury Shares registered a high of $1.8 million during Q4 2024, and its lowest value of $804797.0 during Q4 2022.
- Over the past 4 years, Rhythm Pharmaceuticals' median Treasury Shares value was $1.0 million (recorded in 2021), while the average stood at $1.2 million.
- Its Treasury Shares has fluctuated over the past 5 years, first plummeted by 1582.9% in 2022, then soared by 6537.18% in 2024.
- Rhythm Pharmaceuticals' Treasury Shares (Quarter) stood at $956145.0 in 2021, then dropped by 15.83% to $804797.0 in 2022, then skyrocketed by 37.25% to $1.1 million in 2023, then surged by 65.37% to $1.8 million in 2024.
- Its Treasury Shares was $1.8 million in Q4 2024, compared to $1.1 million in Q4 2023 and $804797.0 in Q4 2022.